Clinical Trials Directory

Trials / Completed

CompletedNCT04806815

Menstrual Cycle-induced Pain, Fatigue and Anxiety in Women Suffered From COVID-19

Status
Completed
Phase
Study type
Observational
Enrollment
180 (actual)
Sponsor
Biruni University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers

Summary

The effects of COVID-19 on body systems and functions are still being investigated. ACE 2, which plays a key role in the entry of the COVID-19 virus into the cell, is also highly expressed in the ovary, uterus, vagina, and placenta in the female genital system, which can also pose a risk to female reproductive health. The aim of this study is to evaluate menstrual cycle-induced pain, fatigue and anxiety in women who suffered from COVID-19.

Detailed description

The effects of COVID-19 on body systems and functions are still being investigated. ACE 2, which plays a key role in the entry of the COVID-19 virus into the cell, is also highly expressed in the ovary, uterus, vagina, and placenta in the female genital system, which can also pose a risk to female reproductive health. It has been examined that menstruation volume decreased or cycle lengthened in one-fifth of women who had COVID-19, and this condition was more intense in those who had severe COVID-19. Studies have shown that the possible effects of COVID-19 on the female genital system often remain theoretical hypotheses. In the literature, there was no study in which menstrual dysfunctions and secondary problems caused by the state of inactivity entering our lives during pandemic were discussed in a wide spectrum of women who had COVID-19. Therefore the aim of this study is to evaluate menstrual cycle-induced pain, fatigue and anxiety in women who suffered from COVID-19.

Conditions

Interventions

TypeNameDescription
OTHERA survey of 60 questions was created through the internet-based 'Google Forms surveys' site.The following tests will be used together with the survey; * Menstrual Symptom Questionnaire * Fatigue Severity Scale * Short Form Of Coronavirus Anxiety Scale

Timeline

Start date
2021-05-18
Primary completion
2021-05-30
Completion
2021-06-01
First posted
2021-03-19
Last updated
2021-06-30

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04806815. Inclusion in this directory is not an endorsement.